Dr. Clifton Bingham III, MD

• Rheumatology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Columbia University Vagelos College Of Physicians And Surgeons

  Medical School, 1990

• Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab, 2022-08-25

• Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab, 2016-06-15

• Assessing the Content Validity of Patient-Reported Outcome Measures in Adult Myositis: A Report from the OMERACT Myositis Working Group, 2020-06-17

• Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases, 2014-12-23

• The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study, 2023-04-22

• Using Patient Reported Outcomes and PROMIS in Research and Clinical Applications: Experiences from the PCORI Pilot Projects, 2016-02-25

• The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies, 2022-01-03

• The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis, 2015-03-20

• The Effect of Glucosamine and/or Chondroitin Sulfate on the Progression of Knee Osteoarthritis: A GAIT Report, 2010-02-10

• Association of Pain Centralization and Patient-Reported Pain in Active Rheumatoid Arthritis, 2020-07-21

• Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature, 2017-09-21

• Patient-reported Outcomes and Adult Patients' Disease Experience in the Idiopathic Inflammatory Myopathies. Report from the OMERACT 11 Myositis Special Interest Group, 2014-01-15

• Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils, 2017-09-25

• Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity, 2015-11-27

• Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy, 2019-04-18

• MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments, 2011-10-26

• Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry, 2023-04-15

• Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion, 2019-02-15

• A Survey of Delphi Panelists after Core Outcome Set Development Revealed Positive Feedback and Methods to Facilitate Panel Member Participation, 2018-06-30

• Feasibility and Domain Validation of RA Flare Core Domain Set: A Report of the OMERACT 2014 RA Flare Group Plenary, 2015-02-15

• Matrix metalloproteinases and inhibitors in cartilage tissue engineering, 2011-02-24

• Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report, 2017-08-15

• Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors, 2023-08-07

• Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept, 2016-05-26

• Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD), 2015-07-22

• Autoantibodies Targeting Telomere-Associated Proteins in Systemic Sclerosis, 2021-01-25

• The delivery of evidence-based preventive care for older Americans with arthritis, 2010-07-16

• The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials, 2022-04-05

• Perspectives of survivors, families and researchers on key outcomes for research in acute respiratory failure, 2017-07-29

• More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions, 2015-03-01

• Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study, 2023-05-10

• Core Domains for Clinical Research in Acute Respiratory Failure Survivors: An International Modified Delphi Consensus Study, 2017-03-18

• Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators, 2020-03-13

• Statin use and MRI subchondral bone marrow lesion worsening in generalized osteoarthritis: longitudinal analysis from Osteoarthritis Initiative data, 2022-01-19

• Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials, 2015-04-16

• Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation, 2019-03-22

• Increased pretreatment serum IFN-ß/a ratio predicts non-response to tumour necrosis factor a inhibition in rheumatoid arthritis, 2015-11-06

• Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda, 2015-09-15

• Pain and Catastrophizing in Patients with Rheumatoid Arthritis: A prospective observational cohort study, 2018-04-26

• Montreal Accord on Patient-Reported Outcomes Use Series - Paper 4: Patient Reported Outcomes (PRO) Can Inform Clinical Decision-Making in Chronic Care, 2017-04-20

• Talbot phase-contrast X-ray imaging for the small joints of the hand, 2011-08-12

• Updating the OMERACT Filter: Core Areas as a basis for defining core outcome sets, 2014-03-15

• Clinical efficacy and safety over two years use of glucosamine, chondroitin sulfate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: a GAIT report, 2010-06-04

• Identifying Minimal and Meaningful Change in PROMIS®for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives, 2022-03-03

• Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis, 2018-01-11

• Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen, 2018-03-22

• Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions, 2015-06-05